S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
[BREAKING] Small Firm Develops World's First Anti-Aircraft Laser (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Asian shares mostly rise despite worries about US debt talks
Buy THIS stock before Taiwan is attacked (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
Buy THIS stock before Taiwan is attacked (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain
S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
[BREAKING] Small Firm Develops World's First Anti-Aircraft Laser (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Asian shares mostly rise despite worries about US debt talks
Buy THIS stock before Taiwan is attacked (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
Buy THIS stock before Taiwan is attacked (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain
S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
[BREAKING] Small Firm Develops World's First Anti-Aircraft Laser (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Asian shares mostly rise despite worries about US debt talks
Buy THIS stock before Taiwan is attacked (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
Buy THIS stock before Taiwan is attacked (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain
S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
[BREAKING] Small Firm Develops World's First Anti-Aircraft Laser (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Asian shares mostly rise despite worries about US debt talks
Buy THIS stock before Taiwan is attacked (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
Buy THIS stock before Taiwan is attacked (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain
OTCMKTS:ATMS

Artemis Therapeutics (ATMS) Stock Forecast, Price & News

$1.89
+1.38 (+270.59%)
(As of 05/19/2023 08:48 PM ET)
Compare
Today's Range
$0.30
$1.89
50-Day Range
$0.17
$1.89
52-Week Range
$0.11
$5.00
Volume
3,000 shs
Average Volume
3,007 shs
Market Capitalization
$211.74 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

ATMS stock logo

About Artemis Therapeutics (OTCMKTS:ATMS) Stock

Artemis Therapeutics, Inc. is a biopharmaceutical company. It develops new treatments for serious and life-threatening infections. It Includes cytomegalovirus and malaria. The company was founded on April 22, 1997 and was headquartered in New York, NY.

Receive ATMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Artemis Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ATMS Stock News Headlines

This MMJ Stock Needs To Be At The Top Of Your Radar!
With the MMJ Boom this one stock is separating itself from all the others for good reason
Nasa reveals new spacesuit for Artemis moon landing
Artemis Therapeutics Inc. (ATMS)
This MMJ Stock Needs To Be At The Top Of Your Radar!
With the MMJ Boom this one stock is separating itself from all the others for good reason
Artemis Therapeutics Inc
Nasa’s Artemis 1 moon mission explained
See More Headlines
Receive ATMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Artemis Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ATMS Company Calendar

Today
5/21/2023
Next Earnings (Estimated)
5/22/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Miscellaneous chemical products
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:ATMS
Employees
1
Year Founded
N/A

Profitability

Net Income
$-1,360,000.00
Pretax Margin
-435.69%

Debt

Sales & Book Value

Annual Sales
$310,000.00
Book Value
($0.01) per share

Miscellaneous

Free Float
103,687,000
Market Cap
$211.74 million
Optionable
Not Optionable
Beta
-1.92

Key Executives

  • Shimon Citron
    Chief Executive Officer & Director
  • Haim Tabak
    Chief Operating Officer
  • David Dana
    Chief Financial Officer
  • Dana Wolf
    Chief Medical Officer













ATMS Stock - Frequently Asked Questions

How have ATMS shares performed in 2023?

Artemis Therapeutics' stock was trading at $1.16 on January 1st, 2023. Since then, ATMS shares have increased by 62.9% and is now trading at $1.89.
View the best growth stocks for 2023 here
.

Are investors shorting Artemis Therapeutics?

Artemis Therapeutics saw a drop in short interest in the month of April. As of April 15th, there was short interest totaling 100 shares, a drop of 83.3% from the March 31st total of 600 shares. Based on an average trading volume of 4,000 shares, the short-interest ratio is currently 0.0 days.
View Artemis Therapeutics' Short Interest
.

When is Artemis Therapeutics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 22nd 2023.
View our ATMS earnings forecast
.

What is Artemis Therapeutics' stock symbol?

Artemis Therapeutics trades on the OTCMKTS under the ticker symbol "ATMS."

How do I buy shares of Artemis Therapeutics?

Shares of ATMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Artemis Therapeutics' stock price today?

One share of ATMS stock can currently be purchased for approximately $1.89.

How much money does Artemis Therapeutics make?

Artemis Therapeutics (OTCMKTS:ATMS) has a market capitalization of $211.74 million and generates $310,000.00 in revenue each year.

How can I contact Artemis Therapeutics?

Artemis Therapeutics' mailing address is 18 EAST 16TH STREET SUITE 307, NEW YORK NY, 10003. The official website for the company is www.artemis-therapeutics.com. The company can be reached via phone at (646) 233-1454, via email at ir@artemis-therapeutics.com, or via fax at 800-253-5177.

This page (OTCMKTS:ATMS) was last updated on 5/22/2023 by MarketBeat.com Staff

My Account -